Fundamentally new anti-infective drugs have been developed, which propose an alternative to the traditional preparations (antibiotics and probiotics); their mechanism of action is based on the capacity to enhance

protective potential of external covers and mucous membranes of a macroorganism by means of stimulation of antimicrobial substances production by the normal microflora. Microbial stimulators of bacterial antagonism (MSBA) are suggested for use as probiotics, prebiotics and functional nutritive of a new generation, which favors high resistance of the population to infectious diseases.

FIELD OF APPLICATION: Medicine; Food Industry.

Characteristics of the proposed MSBA products and their strains producers have no analogs; the new mechanism of action is offered,  namely, the stimulation of antimicrobial substances production by microorganisms; adjustment of drugs to the patient is envisioned.

Characteristics of the proposed services to develop new anti infective drugs: the capacity to strengthen antagonism of bacteria is a new property of microorganisms which can be used for development of new probiotics, prebiotics and functional nutritive; it has no analogs.

 Field of Application: treatment and prophylactic of infectious diseases.

Antagonism of Enterococcus faecium toward

pathogenic Staphylococcus aureus under the

MSBA effect of different bacteria